Vaikom Mahadevan to Treatment Outcome
This is a "connection" page, showing publications Vaikom Mahadevan has written about Treatment Outcome.
Connection Strength
0.674
-
Tuwairqi K, Salahuddin A, Judson G, Blusztein D, Moore P, Anwar S, Mahadevan VS. First in Human: Transcatheter Repair of Isolated Partial Anomalous Pulmonary Venous Return. Circ Cardiovasc Interv. 2022 09; 15(9):e012132.
Score: 0.091
-
Melo D, Agrawal H, Parikh DS, Sarwary S, Lin S, Choy HH, Mallawaarachchi I, Kallianos K, Hope M, Mahadevan VS. Accuracy of Ferumoxytol-Enhanced MRA-Guided TAVR in Patients With Chronic Kidney Disease. JACC Cardiovasc Interv. 2022 03 28; 15(6):677-679.
Score: 0.089
-
Caughron H, Parikh D, Allison Z, Deuse T, Mahadevan VS. Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease. Catheter Cardiovasc Interv. 2021 07 01; 98(1):159-167.
Score: 0.082
-
Singh SP, Agrawal H, Eichler CM, Mahadevan VS. Percutaneous exclusion of post-transcatheter aortic valve replacement (TAVR) induced aortic pseudoaneurysm using an Amplatzer Vascular Plug 2 (AVP2). BMJ Case Rep. 2019 Jul 02; 12(7).
Score: 0.073
-
Kheiwa A, Divanji P, Mahadevan VS. Transcatheter pulmonary valve implantation: will it replace surgical pulmonary valve replacement? Expert Rev Cardiovasc Ther. 2018 Mar; 16(3):197-207.
Score: 0.067
-
Mahadevan VS, Manoly I, Hasan R. 2-Year Follow-Up of the First in Human Transapical Implantation of Transcatheter Inverted Aortic Valve to Treat Native Mitral Valve Stenosis. JACC Cardiovasc Interv. 2015 Dec 28; 8(15):e247-e249.
Score: 0.058
-
Kesarwani M, Ports TA, Rao RK, Mahadevan VS. First-in-Human Transcatheter Pulmonic Valve Implantation Through a Tricuspid Valve Bioprosthesis to Treat Native Pulmonary Valve Regurgitation Caused by Carcinoid Syndrome. JACC Cardiovasc Interv. 2015 Aug 24; 8(10):e161-e163.
Score: 0.056
-
Soni K, Kesarwani M, Badhwar N, Mahadevan VS. Percutaneous Closure of a Residual Left Atrial Appendage Leak After Lariat Procedure. JACC Cardiovasc Interv. 2015 Jun; 8(7):998-1000.
Score: 0.055
-
Krishna MM, Joseph M, Ezenna C, Pereira V, Rossi R, Akman Z, Rubens M, Mahadevan VS, Nanna MG, Goldsweig AM. TAVR vs. SAVR for severe aortic stenosis in the low and intermediate surgical risk population: An updated meta-analysis, meta-regression, and trial sequential analysis. Cardiovasc Revasc Med. 2025 Oct; 79:78-89.
Score: 0.028
-
Dimas VV, Babaliaros V, Kim D, Lim DS, Morgan G, Jones TK, Armstrong AK, Berman D, Aboulhosn J, Mahadevan VS, Gillespie MJ, Balzer D, Zellers T, Yu X, Shirali G, Parthiban A, Leipsic J, Blanke P, Zahn E, Shahanavaz S. Multicenter Pivotal Study of the Alterra Adaptive Prestent for the Treatment of Pulmonary Regurgitation. JACC Cardiovasc Interv. 2024 Oct 14; 17(19):2287-2297.
Score: 0.026
-
Marcus SG, Mahadevan VS, Deuse T. Hybrid Open Minimally Invasive Transcatheter Mitral Valve Replacement. Ann Thorac Surg. 2018 08; 106(2):e57-e59.
Score: 0.017
-
Agrawal H, Mahadevan VS, Shunk K, Lee MS. Fractional Flow Reserve and Intravascular Ultrasound of Coronary Artery Lesions Beyond the Left Main: A Review of Literature. Rev Cardiovasc Med. 2018 Mar 30; 19(1):1-11.
Score: 0.017
-
Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, Wang DD, Greenbaum A, Mahadevan VS, Holzhey D, O'Hair D, Dumonteil N, Rod?s-Cabau J, Piazza N, Palma JH, DeLago A, Ferrari E, Witkowski A, Wendler O, Kornowski R, Martinez-Clark P, Ciaburri D, Shemin R, Alnasser S, McAllister D, Bena M, Kerendi F, Pavlides G, Sobrinho JJ, Attizzani GF, George I, Nickenig G, Fassa AA, Cribier A, Bapat V, Feldman T, Rihal C, Vahanian A, Webb J, O'Neill W. Transcatheter Mitral Valve Replacement in?Native?Mitral Valve Disease With Severe?Mitral?Annular Calcification: Results From the First Multicenter Global Registry. JACC Cardiovasc Interv. 2016 07 11; 9(13):1361-71.
Score: 0.015